Armata Pharmaceuticals Inc. buy Ruckelsbuckel
Start price
08.01.22
/
80%
€4.52
Target price
08.01.23
€52.00
Performance (%)
-3.98%
End price
28.01.22
€4.34
Summary
This prediction ended on 28.01.22 with a price of €4.34. With a performance of -3.98%, the BUY prediction for Armata Pharmaceuticals Inc. by Ruckelsbuckel closed slightly in the red. Ruckelsbuckel has 80% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Armata Pharmaceuticals Inc. | 8.187% | 8.187% | 162.411% |
iShares Core DAX® | 2.149% | 5.415% | 21.385% |
iShares Nasdaq 100 | 0.838% | 1.926% | 44.386% |
iShares Nikkei 225® | 1.143% | 2.887% | 27.641% |
iShares S&P 500 | 1.265% | 3.698% | 33.327% |
According to Ruckelsbuckel what are the pros and cons of Armata Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth > 30% per year expected
Fair valuation
positive Cash Flow expected
Good rating
Standard Investments for future growth
Valuable balance sheet
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Capable Management
Leading role in innovation
Differentiated customer and product portfolio
Growths faster than the competition
Medium risks for its business
Very small cyclical dependencies
Known brand
Strong uniques
Sustainability is important
Stable Large shareholder and/or long term investor
Market Leader or Top 3
Future proof or reliable business model
Very good company culture
Cons
Low dividend yield expected
Lower EBIT Margin than peer group
Comments by Ruckelsbuckel for this prediction
In the thread Armata Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 52,0
In the thread Trading Armata Pharmaceuticals Inc.
Buy beendet